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Thymus-derived regulatory T cells (Tregs) are considered to be a distinct T-cell lineage that is genetically programmed and
specialised for immunosuppression. This perspective is based on the key evidence that CD25+ Tregs emigrate to neonatal spleen
a few days later than other T cells and that thymectomy of 3-day-old mice depletes Tregs only, causing autoimmune diseases.
Although widely believed, the evidence has never been reproduced as originally reported, and some studies indicate that Tregs
exist in neonates. Thus we examine the consequences of the controversial evidence, revisit the fundamental issues of Tregs and
thereby reveal the overlooked relationship of T-cell activation and Foxp3-mediated control of the T-cell system. Here we provide
a new model of Tregs and Foxp3, a feedback control perspective, which views Tregs as a component of the system that controls
T-cell activation, rather than as a distinct genetically programmed lineage. This perspective provides new insights into the roles
of self-reactivity, T cell–antigen-presenting cell interaction and T-cell activation in Foxp3-mediated immune regulation.
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DISCOVERY OF IMMUNOSUPPRESSIVE T CELLS
T cells not only induce immune response using cytokines and surface
molecules but can also suppress it.1–4 T-cell-mediated immunosuppres-
sion was discovered soon after the discovery of thymus as a component
of the immune system.1 Previous studies had identiﬁed immunosup-
pressive activity in CD8 T cells that were designated suppressor T cells.1
Although44500 papers were published, the area collapsed in the 1980s
largely owing to the absence of the ‘suppressor gene’, the I-J gene, that
had been believed to track the suppressor T-cell population.5 In the
1990s, the concept of T-cell-mediated suppression revived through the
characterisation of suppressive CD4 T-cell populations by two experi-
mental systems: (1) induction of autoimmunity by neonatal thymect-
omy; and (2) transfer of T-cell populations depleted of speciﬁc cell
types into lymphopenic mice.3,6 These studies identiﬁed CD5high,
CD25+ and CD45RBlow as the makers of the immunosuppressive
T-cell population and designated these cells as regulatory T cells
(Tregs).2,3 Later, the discovery of Foxp3 as a deﬁnitive marker of Tregs
facilitated the investigation of this T-cell population at molecular and
genomic levels.4 Currently, it is accepted that some self-reactive thymic
T cells escape negative selection and express Foxp3 to become thymic
Tregs (tTregs), which suppress self-reactive T cells in the periphery, and
thus prevent autoimmunity and maintain immunological tolerance.2–4
THE CONTROVERSIAL EVIDENCE OF NEONATAL TREGS
Neonatal thymectomy as the key evidence of tTregs
Originally, Nishizuka and Sakakura7 found that thymectomy of 3-day-
old neonatal mice induced T-cell-mediated autoimmunity in the ovary
and testis, while thymectomy of mice47 days old did not do so.7 The
authors hypothesised that helper (Th) T cells are already matured in
3-day-old mice, while suppressor T cells, which are responsible for
preventing autoimmunity, are absent in these mice.8 In fact, the
concept of Tregs gained wide acceptance after the group of Sakaguchi
reported that CD25+CD4+ T cells did not appear in the periphery
(spleen) until 3 days of life, while CD25−CD4+ T cells were already
present in the spleen of 3-day-old mice, and transfer of CD25+CD4+
T cells prevented thymectomy-induced autoimmunity,9 thus fulﬁlling
the prediction of Nishizuka.8 The ﬁnding that thymectomy selectively
depleted suppressive CD25+CD4+ T cells while leaving autoreactive
CD25−CD4+ T cells present3,9 established the view of CD4+ T cells
that divides them into suppressor and effector cells, thus bridging
classical T-cell-mediated suppression and modern Treg
biology.2,3,6,10–12
Tregs exist in neonates
However, several groups found evidence contradicting Asano et al.9
Suri-Payer et al.13 found around 10% of CD4+CD8− (and/or
CD3bright) lymph node cells from 2-day-old mice express CD25,
and the percentage is identical from 2 days to 6 weeks. Later,
Dujardin et al.14 showed that around 5% of CD4+TCRαβ+ T cells
express CD25 in the spleen of 3-day-old mice on a BALB/c back-
ground. More recently, Samy et al.15 and Monteiro et al.16 showed that
around 5% of T cells from the lymph nodes of 3-day-old mice express
Foxp3, using Foxp3-GFP (green ﬂuorescent protein) knock-in mice or
anti-Foxp3 antibody, respectively, and that the percentage increased
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from day 3 to day 5, reaching to 6–10%. All these ﬁndings argue
against delayed appearance of Tregs in the periphery. Using Foxp3-
GFP knock-in mice, Fontenot et al.17 found that GFP+ thymic CD4
single-positive (SP) cells, which are to be tTregs, rapidly increase after
birth, from ~0% of CD4-SP on day 1 to ~ 4% on day 21, but the
percentages of CD25-expressing cells in CD4-SP do not differ
signiﬁcantly between neonatal and adult mice (both 4–5%).17 Com-
parable data for peripheral T cells were not reported in the study. The
report17 has nevertheless been cited as evidence of delayed appearance
of Tregs in the periphery,11,18 thus further confusing the issues of
Tregs in neonates and thymectomy. Certainly, as thymectomy halts
outﬂow, only T cells in the periphery at the time of thymectomy
contribute to the development of autoimmune disease.
Thus, contrary to the currently accepted opinion, the peripheral
immune system of 3-day-old mice harbours a signiﬁcant proportion
of Tregs, at least half of that of adult mice. This difference between
neonates and adults is much smaller than is widely believed and
therefore unlikely to explain the development of autoimmunity
following day-3 thymectomy, considering particularly that transfer of
o50% of the physiological number of CD25+ T cells into adult mice
can fully suppress the development of autoimmune disease induced by
CD25− T cells.19
Consequences of the controversial evidence
Although there are a pile of molecular data on Foxp3,4 the confusion
over neonatal Treg development is still a modern problem. It has led
to a misunderstanding of the dynamic regulation of CD25 and Foxp3
in neonates and a dismissal of the developmental and regulatory
relationship between activated T cells and Tregs. On the contrary to
the common belief that is based on the controversial evidence,2,3,10
CD25 expression in fact occurs at the same time when CD4+
T cells are generated and matured in the thymus.14–16 This strongly
suggests that CD25 expression is a part of an essential mechanism of
CD4+ T-cell development, rather than a unique feature of specialised
cells. In fact, CD25 is not only a Treg marker but also an activation
marker, and Tregs are similar to activated T cells, apart from their
Foxp3 expression and poor production of effector cytokines.2,3,10 Thus
the development and the phenotype of Tregs are inherently inter-
related with T-cell activation, which is a highly dynamic process. The
current dogma, however, over-relies on the expression of a set of
transcription factors and their stability and dismisses the dynamic
regulations of T-cell response, which always accompanies
T-cell activation and subsequent differentiation. It is hoped to
obtain a dynamical systems view on how the T-cell system is
controlled by these processes, in order to fully understand
Treg-mediated regulation.
AN ALTERNATIVE MODEL OF TREGS AND FOXP3: A FEEDBACK
CONTROL PERSPECTIVE
Accordingly, we propose an alternative view on Tregs and Foxp3, a
feedback control perspective, which views Tregs as a component of the
system that controls T-cell activation, as opposed to the current
dogma, the lineage perspective, which considers that the suppressive
mechanism is retained in a distinct lineage of T cells or Tregs.
The feedback control perspective is composed of the following three
major hypotheses: (1) When an antigen niche (that is, a whole set of
antigen-presenting cells (APCs) that present a particular antigen on
class II major histocompatibility complex (MHC)) is available,
whether in the thymus or in the periphery, T cells with high-afﬁnity
T-cell receptors (TCRs) for the antigen interact with the APCs and
thus ﬁll the niche; (2) Upon interacting with the cognitive antigen,
T cells are activated, producing CD25+ activated T cells (or CD25+
CD4-SP in the thymus). These T cells later generate Foxp3+ T cells
(Tregs) and Foxp3− memory(-like) T cells (Box 1); (3) Memory-like
T cells and Tregs always compete for binding to APCs in each
antigenic niche in the periphery and thereby protect the niche from
naive T cells, which have low-yet-signiﬁcant afﬁnity TCRs to the
antigen (Figure 1a).
This control mechanism should produce two different types of
T-cell response in the periphery. New antigens, to which existing
Tregs/memory-like T cells do not have signiﬁcant cross-reactivity,
activate naive T cells only. The naive-derived activated T cells act as
positive regulators via a self-ampliﬁcation of activated T cells (by, for
example, autocrine interleukin (IL)-2 and IL-2R), while some of them
later express Foxp3 and act as a delayed negative regulator by
promoting the resolution of T-cell activation (Figure 1b). Because of
the delay in the negative regulation, the system exhibits a prolonged
T-cell response (Figure 1c). On the other hand, self-antigens and
previously recognised antigens can induce an immediate response of
both memory-like T cells and Tregs (Figure 1d). Thus such antigens
should produce a faster and shorter T-cell response, because both
positive (activated memory-like T cells) and negative (Tregs) regula-
tors are triggered immediately (Figure 1e). Although the signiﬁcance of
implementing these two types of T-cell response of different speeds in
response to the two types of antigens is yet to be revealed by a
combination of experiments and mathematical modelling, we expect
that these two mechanisms are indispensable for the antigen-speciﬁc
response of CD4 T cells, while tolerating self-antigens, as we
discuss below.
REVISIT KEY EVIDENCE OF TREG-MEDIATED IMMUNE
REGULATION
We may now critically review and examine the key evidence of Treg-
mediated tolerance, propose novel hypotheses from the feedback
control perspective and suggest critical experiments to address those
hypotheses.
The self-reactive T cells: Tregs and memory-like T cells
The lineage perspective considers that some of self-reactive T cells
escape negative selection in the thymus and are selected as tTregs to
control self-reactive naive T cells in the periphery.2–4 The feedback
control perspective hypothesises, based on a range of evidence
discussed below, that naturally arising memory-like T cells partially
originate from those self-reactive T cells in the CD25+ CD4-SP
fraction in the thymus, which is currently considered as the source
of Tregs (Figure 1a).
The major evidence that supports this hypothesis comes from
transgenic (Tg) TCR studies. It is well-known that T cells with a Tg
TCR more preferentially become CD25+ Tregs in the presence of a
deﬁned (Tg) cognitive peptide.20 Furthermore, DO11.10 TCR Tg,
Box 1 Memory-like T cells
Memory-like, or memory phenotype, is a commonly used term to phenotypically
deﬁne a T-cell population typically by the following markers: CD44highCD45R-
BlowFoxp3− CD25−. Although this population does not include Tregs and naive
T cells and contains antigen-experienced memory T cells, the memory-like
T cells, as a population, may have different properties to individual antigen-
experienced memory T cells, which are produced by immunisation or infection in
an antigen-speciﬁc manner, especially in their proliferative activity in vivo.66
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Rag2−/− mice do not develop CD25+CD4+ T cells21 (which in fact
include both Foxp3+ and Foxp3− T cells; see below), and thus Treg
development requires the recombination of the endogenous TCRα for
their development, which supports that Tregs develop only when they
interact with cognitive antigens. Notably, however, DO11.10 TCR Tg,
Rag2−/− mice do not develop CD45RBlowCD44high memory-like
T cells either,22 the signiﬁcance of which has not been addressed
to date.
The interaction between T cells and antigen–MHC complexes may
be the most important determinant for the generation of Tregs (and
probably also the memory-like T-cell population). The absolute
number, not the percentage, of each Foxp3+ Treg clone had an upper
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limit (at the order of 104) by a bone marrow chimera study using
various ratios of wild-type T cells and T cells from a TCR Tg strain
expressing a Treg TCR.23 In addition, lower chimerism of Treg TCR
Tg cells induced higher Nr4a1 expression using a Nr4a1-GFP reporter
Tg strain, whose GFP expression reﬂects the strength of TCR signal.24
Each antigenic niche may have a limited capacity that supports those
self-reactive T cells, including both Tregs and memory-like T cells,
which is experimentally testable using bone marrow chimeras of
various TCR Tg.
Tg reporter studies have provided another line of evidence for the
self-reactivity of Tregs. Using a Foxp3 GFP knock-in mouse strain
with either a null allele or a truncated and dysfunctional protein, GFP+
cells, which lack the expression of functional Foxp3 protein, showed a
CD25+ or− CD45RBlow Treg-like or activated/memory-like phenotype
without suppressive activity.25,26 This suggests that their TCRs were
self-reactive sufﬁcient to induce and maintain the activated phenotype.
Repertoire studies, however, have not been conclusive to the self-
reactivity of tTregs. Some studies showed that Foxp3+CD4+ T cells had
a different TCR repertoire from Foxp3−CD4+ T cells,27–29 while others
showed that TCR repertoires of Tregs and naive T cells were
overlapping30 and that the same peptide selected both Foxp3+CD4+
T cells and Foxp3−CD4+ T cells.31 Similarly, repertoire studies only
compared the bulk Foxp3+ and Foxp3−CD4+ T cells and dismissed to
analyse Foxp3−CD4+ memory-like T cells, which presumably experi-
enced cognitive antigens. Thus the observed difference of TCR
repertoire between the bulk Foxp3+ and Foxp3−CD4+ T cells27–29
may rather reﬂect the difference between antigen-recognised and non-
recognised T cells, as naive T cells dominate the Foxp3−CD4+
T-cell fraction. It will be necessary to compare the TCR repertoires
of Foxp3+ Tregs, Foxp3− memory-like T cells and naive CD4+ T cells.
Tonic TCR signalling and Tregs
The original tonic-signalling hypothesis assumes that memory T cells
maintain their reactivity by constantly interacting with antigen–MHC
complexes in the periphery.32 This continuous ‘subthreshold’ recogni-
tion of self-peptide−MHC complexes is thought to result in a basal
activation state that enables T cells to rapidly respond to foreign
antigen33 and possibly ‘tuning’ T-cell responsiveness to self-antigens.34
Klein et al.33 recently proposed that self-reactive thymic T cells are
selected as CD5high T cells and receive tonic TCR signalling in the
periphery. Interestingly, self-reactive thymic T cells increase the
expression of CD5,33 which is a negative regulator of TCR
signaling,35 while the high expression of CD5 is a classical marker
of a Treg population.2,3 In agreement with these ﬁndings, the
conditional knockout study of TCRα showed that Tregs received
tonic TCR signalling.36
Using an Nr4a1-GFP Tg reporter, Tregs showed a higher level of
GFP expression than CD25− T cells in the thymus and in the
periphery.24 Importantly, the thymic ‘pre-Treg’ population, CD25+
Foxp3− CD4SP, which we argue include the progenitors of naturally
arising memory-like T cells, had an even higher level of GFP
expression than thymic Foxp3+ CD4-SP.24 Intriguingly, we have
found that CD45RBlow memory-like T cells in the periphery also
had higher GFP expression using the same Nr4a1-GFP reporter Tg
strain (unpublished observation).
Reconciling all the evidence, our feedback control perspective
hypothesises that both Foxp3+ Tregs and memory-like T cells
frequently interact with and compete for antigen–MHC complexes
in the periphery, receiving weak yet frequent signal, tonic TCR signal,
and thereby maintain their activated/memory-like phenotypes and
numbers in each antigenic niche. Then the ratio of the numbers of
Tregs and memory-like T cells in each antigen niche would be
optimally balanced by their plastic Foxp3 transcription, which may be
an alternative explanation for the observed ‘plasticity’ of Tregs.22,37
This plastic Foxp3 transcription may be dependent on transforming
growth factor-β (TGF-β) and IL-2 and Foxp3-conserved noncoding
sequence-1.38 These considerations lead to two experimentally testable
hypotheses: (1) both Tregs and naturally arising memory-like T cells
are lost upon the disruption of tonic signalling, which may lead to the
activation of naive T cells; and (2) foreign antigens can differentiate a
naive T-cell repertoire into Foxp3+ Tregs and memory-like T cells,
which persist and receive tonic signal as long as the antigen is
available.
Re-interpretation of Treg-depletion experiments
A series of cell transfer experiments provided an important line of
evidence, in addition to the neonetal ontogeny experiments, to
establish the current concept of Tregs.2,3,10 Here T-cell suspensions
that were depleted of a T-cell population were transferred into
lymphopenic mice, which were analysed for the development of
autoimmune and/or inﬂammatory diseases. The depletion of CD25+
T cells induced autoimmune gastritis in nude recipients,3 while that of
Figure 1 Feedback control perspective of T-cell regulation. (a) The proposed model for the T-cell regulation is depicted. Self-reactive thymic CD4-SP receive
strong TCR signals from antigen/MHC complex on thymic epithelial cells (TEC) and other APCs. These cells may die by negative selection or survive by
expressing CD25 and upregulating the expression of CD5 (CD5high), which is a negative regulator of TCR signaling. Some CD25+ CD4-SP express Foxp3 and
become Foxp3+ Tregs in the periphery, while some of the others, we argue, become Foxp3− memory-like T cells (memory). On the other hand, thymic T cells
with less self-reactive TCRs may receive weak TCR signals only, remain CD5low, do not express CD25 and become naive T cells in the periphery. Thus both
Tregs and memory-like T cells are more self-reactive than naive T cells and therefore interact more frequently with APCs that present the same or similar self-
antigens in the periphery, receiving tonic TCR signaling, and protecting the antigenic niche from naive T cells. (b) Upon encountering with a totally new
antigen to the immune system, only some of the naive T cells can respond to the antigen and become CD25+ activated T cells. Many of these activated
T cells die by apoptosis (that is, activation-induced cell death), but some differentiate into Tregs, promoting the resolution of the response (negative feedback
control), and others may become memory T cells, after the resolution. Thus a new antigenic niche is created and occupied by both Tregs and memory
T cells, which are maintained by tonic TCR signal in the same manner as for thymus-derived, self-reactive T cells. (c) Control mechanism of naive T cells to
new antigens shown in panel (b). (d) Upon encountering with self-antigen or similar antigen on activated APC, both memory(-like) T cells and Tregs
immediately respond and are activated. Thus the response will be rapid but be resolved earlier because of the negative feedback by the preexisting Tregs. (e)
Control mechanism of memory-like T cells and Tregs to self-antigens or experienced antigens shown in panel (d). (f) Various ‘Treg-depletion’ experiments in
fact provide to naive T cells an access to all antigenic niches. This effect is most dramatic when both Tregs and memory-like T cells are depleted, and naive
T cells have the full access to all niches. (g) Possible mechanism for the control of T-cell activation by transient FOXP3 expression in human activated
T cells. TCR signal induces and activates immediate early genes (IEGs), which transcribe the IL2 gene. IL-2 protein is secreted and received by those
activated T cells in an autocrine manner. IL-2 signal via IL-2R (including CD25) activates STAT5, which positively regulate the activation of IEGs and FOXP3
transcription. FOXP3 represses IEGs by physically interacting with them or repressing their transcription.
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CD45RBlow T cells resulted in colitis in Rag-deﬁcient or SCID
recipients.10 Later, Foxp3 expression was found better correlated with
CD25+ than CD45RBlow, establishing Tregs as CD25+Foxp3+ T
cells.2,3
Although the lineage perspective tells that self-reactive T cells induce
autoimmunity,1–4 this is in fact controversial. Using a Foxp3-GFP
reporter Tg mouse in a Foxp3 mutant scurfy background, Lahl et al.39
showed that GFP+ cells, which have an active Foxp3 transcription
without functional Foxp3 protein and thus considered self-reactive, do
not induce autoimmune inﬂammation when transferred into Rag1−/−
mice. CD45RBhigh CD4+ naive T cells, which are presumably selected
as non-self-reactive T cells in the thymus, efﬁciently induce colitis in
recipients, while CD25−CD45RBlow CD4+ T cells, which are composed
of memory-like T cells and a small amount of Tregs, do not.40
Ono et al.41 showed that the depletion of GITRhigh T cells resulted
in a more aggressive autoimmune disease with wider organ involve-
ments than that of CD25+ T cells by further reducing Foxp3+ T cells
(~2% vs ~ 6%). The suppressive activity in CD45RBlowCD25− or
GITRhighCD25− T cells may be attributable to the small amount
of Foxp3+ Tregs in the fraction.4 However, it may be more
straightforward to assume that both Tregs and memory-like T cells
are engaged in maintaining immunological tolerance through their
high afﬁnity to self-antigens and the plastic Foxp3 transcription. In
fact, memory-like CD25−CD45RBlowCD4+ T cells can generate Foxp3
+ T cells more rapidly than CD25−CD45RBhighCD4+ naive T cells,22
and the memory-like T-cell population in fact contains ex-Foxp3+
Tregs by a genetic fate-mapping experiment.37
Thus the feedback control perspective hypothesises that self-reactive
T cells, which include both Tregs and memory-like T cells, frequently
interact and thereby protect the self-antigen niches from other T cells
with less-stringent TCRs to the individual antigens. Experimental
ablation of both Tregs and memory-like T cells most efﬁciently make
all antigenic niche available to naive T cells, inducing the activation of
a broad repertoire of naive T cells (Figure 1f). Apparently, the
disturbance of the T-cell system by the less-stringent activation of
naive T cells results in autoimmunity, and it is hoped to fully reveal
this mechanism at the network and systems levels.
Paradoxically, Treg depletion may result in less efﬁcient immune
response to viral infection. The depletion of Foxp3+ T cells during
herpes simplex virus infection resulted in an accelerated fatal infection
with increased viral loads, and thus Tregs are thought to facilitate early
protective responses to local viral infection by allowing a timely entry
of immune cells into the infected tissue.42 A similar observation was
obtained by an immunisation experiment, where Treg depletion
decreased the efﬁciency of immunisation.43 Under the feedback
control perspective, the depletion of the entire Foxp3+ population
empties all the antigen niches for Tregs, and thus induces the
conversion of memory-like T cells to Tregs, and the activation of
naive T cells, in order to ﬁll the niches. This will induce less-stringent
immune reactions, and deprive immunological resources for virus-
speciﬁc T cells, and thereby decrease the efﬁciency of antiviral immune
response. These lead to a hypothesis that the depletion of virus-speciﬁc
Foxp3+ T cells only after the proper induction of T-cell response (the
resolution phase in Figures 1b and d) may augment and prolong
antiviral response without detrimental effects.
Genetic fate-mapping
Genetic fate-mapping experiments showed that Tregs maintained
Foxp3 expression in a relatively stable manner while the expression
of Foxp3 in original naive T cells tends to be transient.37,44 These
studies, however, dismissed the cellular stability of the population and
the stability of antigen presentation. In fact, while Tregs are more
‘proliferative’ in vivo because they incorporate more bromodeoxyur-
idine than non-Treg CD4+ T cells,45,46 Tregs seem to be always dying
at a faster rate than other T cells. A genetic ablation of TCRα abolished
bromodeoxyuridine incorporation in Tregs and resulted in a gradual
loss of Treg population, a half-life of which was 6 weeks.36 In addition,
these Tregs lost the activated (that is, regulatory) phenotype, although
Foxp3 expression was mostly maintained.36 Collectively, these
evidence strongly suggest that a continuous proliferation, induced by
tonic TCR signaling, is required to maintain the size of the Treg
population.
Importantly, a fate-mapping study showed that there was a
signiﬁcant ﬂow into the memory-like Foxp3−CD44high cells from the
T cells that once expressed Foxp3.37 Considering that memory-like
T cells more efﬁciently generate Foxp3+ T cells than naive T cells,22
Tregs and memory-like T cells may be in a close relationship and
change their phenotypes to each other, obtaining an equilibrium in
each antigenic niche.
Accordingly, we hypothesise that individual Treg survive, as long as
their cognitive antigen niches are available (Figure 1). This leads to the
following experimentally testable hypotheses: (1) Foxp3 expression in
original naive T cells may not sustain if their cognitive antigens are
occupied by existing Tregs; (2) the removal of a set of antigens may
eliminate a repertoire of Tregs; and (3) a completely new external
antigen that cannot be recognised by potentially cross-reactive T cells
may create a new antigenic niche and thus induce Foxp3 expression in
Foxp3− T cells. To address these questions, we need to understand the
temporal dynamics of T-cell numbers and phenotypes, as in our
feedback control perspective, and to establish a new experimental
method to identify newly generated Tregs or induced Tregs.
Treg subsets
tTregs can acquire a part of Th cell differentiation mechanisms in the
periphery and thereby control corresponding Th cell response. Tbx21-
deﬁcient Foxp3+ T cells fail to suppress the Th1-type inﬂammation of
a Foxp3 hypomorphic mutant, scurfy mice.47 Similarly, the Foxp3+ T
cell-speciﬁc deletion of Irf4, which is required for Th2 differentiation,
results in the dysregulation of Th2 response,48 and Foxp3+ T cell-
speciﬁc deletion of a Th17 factor, Stat3, results in a Th17-mediated
colitis. Notably, Stat3-deﬁcient Tregs lack the expression of C-C motif
chemokine receptor 6 and fail to migrate to the colon tissue.49 The
deletion of peroxisome proliferator-activated receptor-γ resulted in a
speciﬁc impairment of Tregs to localise in visceral adipose tissue.50
Upon immunisation, some Foxp3+ Tregs express Blimp1 and acquire
a number of features that share with T follicular helper cells (TFH) and
are called as follicular Tregs. A cell transfer experiment showed that
follicular Tregs were derived from tTregs.43 These evidence are in
favour of the lineage perspective, as bulk ‘naive’ Tregs can undergo
further differentiation into more specialised Tregs, acquiring effector
molecules, such as IL-10, tissue localisation and speciﬁc transcription
factors.
On the other hand, as discussed above, the feedback control
perspective predicts that a Treg subset may immediately develop from
tTregs if existing tTregs have a TCR repertoire that is cross reactive to
the immunised peptide, and otherwise naive T cells are activated and
differentiated into a set of Tregs and memory-like/effector T cells that
are adapted to a cytokine milieu or an anatomical location (for
example, follicular Tregs and TFH; Figures 1b and d).
At the molecular level, T cells may activate multiple differentiation
programmes irrespective of Foxp3 expression, which is compatible
with the ﬁndings above.47–50 For example, the transcriptional
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regulation of Tbx21, Irf4 and Stat3 seem independent from Foxp3
expression.47–49 This Foxp3-independent control of effector differen-
tiation programmes may be especially important for enhancing the
outputs of the memory-type control of T-cell activation (Figures 1d
and e), which is considered inherently rapid but short by the
preexisting negative and positive regulators. When multiple differ-
entiation programmes need to be considered at the genomic level, it is
essential to employ a multidimensional approach, and also, visualisa-
tion is critically important, as we discussed elsewhere.51,52
Molecular mechanism of Foxp3
Foxp3 has been regarded as a ‘master control gene’ of Tregs in the
lineage perspective. However, accumulating evidence suggest that
Foxp3 is involved in, and a part of, the T-cell activation mechanism.
New Foxp3 transcription occurs in activated T cells in the presence of
IL-2 and TGF-β.37,53 Although TGF-β is produced by various cells
in vivo,54 IL-2 is produced mainly by CD44high memory-like and
activated T cells in the periphery.55,56 Furthermore, the phenotype of
Tregs, which is uniquely similar to activated T cells, is in fact
established by strong TCR signal in the thymus25,26,57 and maintained
by tonic TCR signal in the periphery.36 In addition, a DNase I
hypersensitive site (DHS) sequencing showed that ‘Treg-speciﬁc’ DHS
were mostly independent from Foxp3 expression and were in fact
those of activated T cells, while a chromatin immunoprecipitation
sequencing showed that Foxp3 bound to these TCR-responsive
enhancers.58 Meanwhile, it has been suggested that Foxp3 can bind
to various transcription factors that are used for effector function in
conventional T cells and thereby use them for their regulatory
function.4,48–50,58,59 Yet, importantly, these Foxp3-binding factors are
mostly engaged in T-cell-activation-related events, including cytokine
production and effector/helper T-cell differentiation. On the other
hand, TCR signal is continuously delivered in Tregs,24 presumably
because of their high-afﬁnity TCRs to self and previously recognised
antigens, and thereby sustains their activated phenotype and survival.36
Thus we propose a model that Foxp3 protein is expressed as a
consequence of strong TCR signal and participates and modiﬁes the
TCR-induced transcriptional mechanism, where Foxp3-binding pro-
teins such as nuclear factor of activated T-cells and Runx have
key roles.
Interestingly, in humans, FOXP3 expression is transiently induced
in any activated T cells by simple TCR stimulation.60 Although human
FOXP3high T cells are as suppressive as murine Foxp3+ T cells,
activated T cells with transient FOXP3 expression are not suppressive
on other T cells in in vitro assays and are thought to constitute the
FOXP3lowCD45RA− non-Treg population that produces effector
cytokines.61 FOXP3low activated T cells show a lower, yet signiﬁcant
and equivalent level of FOXP3 expression as a suppressive, naive Treg
population (that is, FOXP3lowCD45RA+ T cells).61 Thus, at the
molecular level, the transiently expressed FOXP3 may act as a negative
regulator of T-cell activation in any activated T cells: activated T cells
produce IL-2, which binds to and activates IL-2R on themselves in an
autocrine manner, and thereby induces and prolongs the FOXP3
expression, while the expressed FOXP3 suppresses IL-2 production62
(Figure 1g). In fact, using Foxp3-null T-cell clone and FOXP3
knockdown in conventional T cells, McMurchy et al.63 showed that
FOXP3 suppressed the proliferation and cytokine production in
activated conventional T cells.
Collectively, FOXP3 regulates T-cell activation by both Treg-
mediated (Figures 1c and e) and non-mediated (Figure 1g) mechan-
isms in humans, while Foxp3 mainly uses the Treg-mediated one in
mice. Importantly, whether Treg-mediated or not, and whether in
humans or in mice, Foxp3 expression occurs as a consequence of
T-cell activation and regulates the T-cell activation via negative
feedback control.
Re-interpretation of neonatal thymectomy by the feedback control
perspective
Given the widespread belief that Tregs are depleted by neonatal
thymectomy,9 there has been confusion over the kinetics of Treg
recovery after thymectomy. The number of CD4 T cells is dramatically
decreased by neonatal thymectomy, in line with the level of
immunosuppression induced by the treatment. The reduction is most
striking in CD45RBhigh naive T cells (~16-fold change) and is less so in
CD25+CD4+ T cells (3–4-fold change) in 2–3 months old, day-3
thymectomised mice, which have relatively higher percentages of
CD25+ or Foxp3+ Tregs.14–16 These CD25+ Tregs are as ‘regulatory’ as
those from non-treated wild-type mice in suppressing the develop-
ment of colitis by cell transfer of CD45RBhigh T cells into Rag2−/−
mice.14
Asano et al.9 found that CD25+CD4+ but not CD25−CD4+ cells
suppress the development of autoimmune diseases caused by neonatal
thymectomy. This is often regarded as evidence of the role of Tregs in
thymectomy-induced autoimmunity.2 However, as neonatal thymect-
omy does not deplete Tregs, the suppression of autoimmune disease
by transfer of Tregs does not imply that it is lack of Tregs that causes
the autoimmune disease. Thus the mechanism of autoimmunity in
thymectomised mice is yet to be revealed.
In the feedback control perspective, neonatal thymectomy
diminishes the number of T cells within the TCR repertoire and
thereby leaves many antigen niches unoccupied and available. The
homeostatic pressure in the lymphopenic environment would induce
the proliferation of a broad range of the naive T-cell repertoire that
occupy those unoccupied niches through their low-yet-signiﬁcant
afﬁnity TCR to self-antigens. Mature CD4+ T cells, especially self-
reactive CD25+CD4+ T cells can prevent the development of auto-
immune disease because they can ﬁll the niche efﬁciently. The
conclusive experiments to test this hypothesis would be to reveal the
dynamics and TCR repertoire of T cells at a single cell level after
thymectomy on various ages of mice, using a combined approach of
experiments and mathematical modelling.
CONCLUSIONS
Here we suggest that the fatal assumption in the study of suppressor
T cells, which had collapsed the ﬁeld, was that the suppressive activity
was retained in a specialised cell or a single molecule. Although Tregs
and Foxp3 act as negative regulators, immune regulation should be
understood as a systems behavior. The proposed feedback control
perspective will provide dynamical systems views to the modern Treg
biology, relating new molecular and systems data to classical evidence.
Although the lineage perspective has been useful for analysing static
relationships between cells and molecules, the proposed feedback
control perspective is required to fully understand the dynamics of the
T-cell system (Table 1) and will open up four important future
directions in the Treg research area. First, the proposed perspective
encourages the investigation of the dynamics of gene expression, cells,
and even epigenetics, at single cell level. In fact, demethylation can
occur within a few hours in some situations,64 and dynamical control
is important in all these molecular and cellular events. Second, the
proposed perspective is concerned with the dynamics rather than the
stability of lineages and hence compatible with the study of systems-
level dynamics based on mathematical modelling and dynamical
systems and control theory, which will provide wider and deeper
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views on the control mechanisms of the T-cell system.52 Third, the
proposed perspective provides a view on how the interaction of TCR
repertoire and antigens from the T cells can induce different types of
immune response. This will lead to a new dimension of T-cell biology,
where the mechanisms of immunological tolerance and memory are
revealed at TCR and antigen repertoire levels. Finally, the proposed
perspective can be further extended to address other negative
regulatory mechanisms in the T-cell system. For example, CTLA-4
(cytotoxic T-lymphocyte-associated protein 4) is inducible by TCR
signaling and negatively regulates the T-cell activation process by
inhibiting the interaction between CD28 and CD80/86 on APC,65
which provides another regulatory layer to the control mechanism of
T-cell activation. Interestingly, CTLA-4 is also highly expressed in both
activated T cells and Tregs.65 Thus the immunoregulatory T pheno-
type may be generalised as a stage of T-cell activation at which negative
feedback mechanisms are actively operating.
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